Portola Pharmaceuticals
PTLA
#5336
Rank
NZ$2.45 B
Marketcap
NZ$31.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Portola Pharmaceuticals (PTLA)

Last known market cap: NZ$2.45 Billion

As of April 2026 Portola Pharmaceuticals has a market cap of NZ$2.45 Billion. This makes Portola Pharmaceuticals the world's 5336th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Portola Pharmaceuticals from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$2.22 B7.58%
2021NZ$2.07 B5.64%
2020NZ$1.96 B-29.02%
2019NZ$2.76 B42.53%
2018NZ$1.93 B-56.66%
2017NZ$4.47 B144.17%
2016NZ$1.83 B-56.76%
2015NZ$4.23 B140.36%
2014NZ$1.76 B37.48%
2013NZ$1.28 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.025 T 41,697.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$277.57 B 11,211.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$202.92 B 8,169.72%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$46.84 B 1,809.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$217.90 B 8,780.09%๐Ÿ‡บ๐Ÿ‡ธ USA